R. Pringle

462 total citations
6 papers, 393 citations indexed

About

R. Pringle is a scholar working on Clinical Biochemistry, Physiology and Ophthalmology. According to data from OpenAlex, R. Pringle has authored 6 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Clinical Biochemistry, 3 papers in Physiology and 2 papers in Ophthalmology. Recurrent topics in R. Pringle's work include Advanced Glycation End Products research (5 papers), Retinal Diseases and Treatments (2 papers) and Clinical Laboratory Practices and Quality Control (1 paper). R. Pringle is often cited by papers focused on Advanced Glycation End Products research (5 papers), Retinal Diseases and Treatments (2 papers) and Clinical Laboratory Practices and Quality Control (1 paper). R. Pringle collaborates with scholars based in United Kingdom, Japan and Netherlands. R. Pringle's co-authors include Alan W. Stitt, C.M. McVicar, Simon Brockbank, Phaik Har Yong, A. Berner, Kôji Uchida, Ryoji Nagai, Tim M. Curtis, R. Hamilton and Deirdre Rogers and has published in prestigious journals such as The Lancet, Diabetologia and Investigative Ophthalmology & Visual Science.

In The Last Decade

R. Pringle

6 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Pringle United Kingdom	4	161	105	97	85	79	6	393
Richard Bucala United States	5	390 2.4×	59 0.6×	53 0.5×	81 1.0×	217 2.7×	9	535
Ines Cilenšek Slovenia	10	62 0.4×	150 1.4×	102 1.1×	15 0.2×	67 0.8×	28	354
Sophia I. Pachydaki United States	9	347 2.2×	273 2.6×	286 2.9×	42 0.5×	90 1.1×	17	700
S. Martin United States	5	333 2.1×	101 1.0×	161 1.7×	54 0.6×	171 2.2×	10	617
Asaad A. Ghanem Egypt	14	54 0.3×	117 1.1×	411 4.2×	39 0.5×	36 0.5×	30	581
D. B. Archer United Kingdom	10	105 0.7×	156 1.5×	177 1.8×	20 0.2×	56 0.7×	22	511
Gurdip Daffu United States	9	278 1.7×	134 1.3×	5 0.1×	51 0.6×	111 1.4×	11	508
Rie Shibayama Japan	8	267 1.7×	81 0.8×	14 0.1×	61 0.7×	147 1.9×	11	413
Rokhsana Mortuza Canada	6	29 0.2×	162 1.5×	62 0.6×	19 0.2×	15 0.2×	9	377
Xinyang Yu China	9	20 0.1×	179 1.7×	38 0.4×	13 0.2×	108 1.4×	12	381

Countries citing papers authored by R. Pringle

Since Specialization

Citations

This map shows the geographic impact of R. Pringle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Pringle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Pringle more than expected).

Fields of papers citing papers by R. Pringle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Pringle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Pringle. The network helps show where R. Pringle may publish in the future.

Co-authorship network of co-authors of R. Pringle

This figure shows the co-authorship network connecting the top 25 collaborators of R. Pringle. A scholar is included among the top collaborators of R. Pringle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Pringle. R. Pringle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Brouwers, Olaf, R. Pringle, Ingeborg Klaassen, et al.. (2011). Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology. Diabetologia. 55(3). 845–854. 129 indexed citations

2.

Curtis, Tim M., R. Hamilton, Phaik Har Yong, et al.. (2010). Müller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products. Diabetologia. 54(3). 690–698. 109 indexed citations

3.

Pringle, R., et al.. (2009). Proteomic Analysis of Advanced Glycation End-Product (Age) Modified Proteins in High Glucose-Exposed Retinal Müller Glia: Evidence for Age-Mediated Cell Dysfunction During Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 50(13). 4992–4992. 1 indexed citations

4.

Mallidis, Con, Ishola Agbaje, Deirdre Rogers, et al.. (2009). Advanced glycation end products accumulate in the reproductive tract of men with diabetes. International Journal of Andrology. 32(4). 295–305. 88 indexed citations

5.

Mallidis, Con, Ishola Agbaje, Deirdre Rogers, et al.. (2007). Advanced Glycation End Products (AGEs) accumulate in the Reproductive Tract of Men with Diabetes.. Reproduction. 1 indexed citations

6.

Pringle, R.. (1965). BLOOD VISCOSITY AND RAYNAUD'S DISEASE. The Lancet. 285(7395). 1086–1089. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact